Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Kans op val verdubbeld na een lichte beroerte of TIA
nov 2023 | Neuro-vasculair